Download presentation
Presentation is loading. Please wait.
Published byHillary Tucker Modified over 9 years ago
1
1 www.euronanomed.net E UROpean network of transnational collaborative RTD projects in the field of NANOMEDicine
2
www.euronanomed.net 2 What are the societal needs? - the challenge for Europe Improve public health and welfare –Ageing population –Efficiency of current medical solutions –Emergence of new disease and old diseases are back –Personalized medicine future directions
3
www.euronanomed.net 3 The global challenge Therapeutic solutions for only 1/3 known diseases (WHO) Infections: HIV, TB, malaria, risk of pandemia Need to increase capability and innovation of medical industry –Rapid and accurate diagnosis for early detection, even prevention –Novel, more efficient therapies with less side effects
4
www.euronanomed.net 4 Nano from research to patient and industry Nanomedicine: the application of nanotechnology to achieve breakthroughs in healthcare Foto: kaibara87/www.flickr.com
5
www.euronanomed.net 5 Principle of the ERA-net scheme F G UK ES DE CP Without ERA-Net Prog F Prog G Prog UK Prog ES Prog DE Common transnational dedicated CP With ERA-Net … (CP: Call for projects) € : EC supports the coordination costs. Each national programme supports their national partners within the selected projects
6
www.euronanomed.net 6 Who we are 24 partners (agencies and ministries) from 18 countries/regions Aligning parts of their national / regional funding programs according to the FP7 ERA-Net scheme Started January 2009 for 3 years for coordination ( EU funding for coordination (FP7) 3 common joint calls for proposals 2009, 2010, 2011 EuroNanoMed achieves a critical mass of actors Joint trans-national RTD projects in nanomedicine
7
www.euronanomed.net 7 EuroNanoMed: an asset to bridge the gap Develop innovative diagnostic and therapeutic solutions for the patient Solving unmet medical needs Enhancing the competitiveness of the European health industry Maturation of the Nanomedicine field in Europe Cross-border collaboration between the best researchers / teams in Nanomedicine, bringing together teams from academic / public research clinical / public health industry Aims of the Calls
8
www.euronanomed.net 8 Why now? What’s the urgency? Health industry: a key for future growth European countries invest substantially in nano industry and basic nano research Nano technologies: a promising field for innovation and patient application Despite these efforts, Europe is lagging behind the US in an increasing competition : Europe needs to act now!
9
www.euronanomed.net 9 Expected outcome To move innovation from knowledge to industrial technology and health care applications Opening the national programmes to support transnational RTD partnerships Long term vision: formula for an European- wide integrated programme with a coordinated funding
10
www.euronanomed.net 10 Contacts Coordinator and Executive Board Chair Dr. Virginie Sivan Commissariat à l’Energie Atomique (CEA) Virginie.sivan@cea.fr (+33) 1 69 08 87 99 Network Steering Committee chair Dr. Olaf Rotthaus VDI Technologiezentrum GmbH (VDI) rotthaus@vdi.de (+49) 211 6214-233
11
www.euronanomed.net 11 Joint Transnational Calls for proposals : RESULTS JTC-1: 2009 JTC-2: 2010
12
www.euronanomed.net 12 RESULTS JTC-1 and JTC-2 Submitted projects2433 Partners117178 Country/region19 Funded projects88 Partners4046 Country/region1410 Success rate33%24% Total costs (M€)16.915.9 Requested budget (M€)9.49 JTC-1 2009JTC-2 2010
13
www.euronanomed.net 13 Submitted projects Partners distribution /country-region JTC-1 JTC-2
14
www.euronanomed.net 14 JTC-1 2009 Submitted projects Category of partners Consortium composition Translational Collaboration JTC-2 2010
15
www.euronanomed.net 15 Submitted projects Main scientific subfields JTC-1 2009 JTC-2 2010
16
www.euronanomed.net 16 Funded projects Partners /country-region France8 Spain8 Germany7 Sweden4 Switzerland3 The Netherlands2 Denmark (NPC)1 Island1 Italy (NPC)1 Veneto Region1 Lithuania1 Poland1 Portugal1 Basque Region1 France10 Germany9 Sweden6 Portugal5 Switzerland5 Spain5 Romania3 Poland1 Turkey1 Latvia1 JTC-1 2009JTC-2 2010 Total 40 Total 46
17
www.euronanomed.net 17 -gene therapy -Immunotherapy -photodynamic therapy -anti-cancer therapies -development of vaccines -regeneration of the nervous system and sensory organs. -cancer -inflammatory diseases -bone regeneration -muscular dystrophy -immunology -vaccines JTC-1 2009JTC-2 2010 Funded projects Main scientific subfields
18
www.euronanomed.net 18 EuroNanoMed: open Call 3 rd Joint Transnational Call for Proposals 14 Countries / Regions Deadline: April 15 th 2011
19
www.euronanomed.net 19 Participating Funding Organisations Industry, Innovation, Trade and Tourism Department, Basque Government The French National Research Agency (ANR) VDI Technologiezentrum GmbH The Icelandic Centre for Research (RANNIS) The Chief Scientist Office, The Ministry of Health (CSO-MOH) The Latvian Academy of Sciences (LAS) Science Council of Lithuania (LSC) National Centre for Research and Development (NCBiR) Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI) Instituto de Salud Carlos III (ISCIII) Swiss National Science Foundation (SNSF) The Scientific and Technological Research Council of Turkey (TUBITAK) Project Unit research and innovation, Veneto Region Ministry of the Walloon Region: Operational General Directorate for Economy, Employment,and Research (DGOEER) BASQUE REGION (SPAIN) FRANCE GERMANY ICELAND ISRAEL LATVIA LITHUANIA POLAND ROMANIA SPAIN SWITZERLAND TURKEY VENETO REGION (ITALY) WALLOON REGION (BELGIUM)
20
www.euronanomed.net 20 Topics / Funding Diagnostics Targeted drug delivery Regenerative medicine Topics Indicative total funding 11 M € Duration: Up to 3 years Every project partner will receive the funding from his national agency Funding
21
www.euronanomed.net 21 Eligibility criteria Consortium composition 3 – 7 partners per consortium Partners from at least 3 different countries (with a majority of partners from funding member states/regions participating in the call) Partners from at least two of the three categories academic / public research clinical / public health industry Eligibility of partners also depends on national regulation in their country or region! Read carefully the “ Country specific information for applicants” Contact your national agency (contact person)
22
www.euronanomed.net 22 Time lines Call open since: January 14 th 2011 Deadline for proposals: April 15 th 2010, 17:00:00 (Brussels Time) Funding Decision: October 2011 Start of Projects:January 2012
23
www.euronanomed.net 23 How to apply? 1. EuroNanoMed Website www.euronanomed.net
24
24 How to apply? 2. Download Call Text, Guidelines for applicants and Country specific Information
25
www.euronanomed.net 25 How to apply? 3. Contact your national contact point (list in the Country-region specific information) 4. Download and fill in the Proposal Template
26
www.euronanomed.net 26 How to apply? 5. Online Submission using the EuroNanoMed Submission Tool www.nanomedsubmission.net
27
www.euronanomed.net 27 How to apply? Register by clicking on the link ”to register” on the homepage http://www.euronanomed.net/*; you will receive an email confirming your registration http://www.euronanomed.net/ Accede to the EuroNanoMed Electronic Submission System* (Use the username and password you chose for the registration) fill in all the details and upload your proposal document (pdf format only), which you have previously filled in on your computer (see The Proposal Template)*. EuroNanoMed Electronic Submission SystemThe Proposal Template Submit your proposal : Click on “submit proposal” to confirm your submission; you will receive an email confirming its receipt. Modify your data at any time until the submission deadline. It is strongly recommended to transfer the final version in proper time before this date
28
www.euronanomed.net 28 Expression of Interest Tool Present your project ideas Find partners www.nanomedsubmission.net
29
www.euronanomed.net 29 For more information Veneto Nanotech s.c.p.a. Via San Crispino, 106 35129 Padova – Italy : +39 049 7705520 e-mail: calloffice@euronanomed.netcalloffice@euronanomed.net EuroNanoMed Call Office National / Regional Contact Points www.euronanomed.net
30
30 www.euronanomed.net Together we are building Nanomedicine for the future!
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.